EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparing Inflammatory Biomarkers in Cardiovascular Disease: Insights from the LURIC Study

Angela P Moissl iD, Graciela E Delgado, Hubert Scharnagl iD, Rüdiger Siekmeier, Bernhard K Krämer iD, Daniel Duerschmied iD, Winfried März iD, Marcus E Kleber iD

International Journal of Molecular Sciences · 29.07.2025 · 26 (15) · 7335

DOI: 10.3390/ijms26157335 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.07.2025. Verfasst von Angela P Moissl und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine I (Cardiology, Hemostaseology, Medical Intensive Care), Medical Faculty Mannheim, University of Heidelberg, 68167 Mannheim, Ge…. Hauptthemen laut MEDLINE: Biomarkers, Cardiovascular Diseases, Interleukin-6, Inflammation. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union Horizon 2020 Program To_aition, Horizon 2020 Program TO_AITION.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory biomarkers, including high-sensitivity C-reactive protein (hsCRP), serum amyloid A (SAA), and interleukin-6 (IL-6), have been associated with an increased risk of future cardiovascular events. While they provide valuable prognostic information, these associations do not necessarily imply a direct causal role. The combined prognostic utility of these markers, however, remains insufficiently studied. We analysed 3300 well-characterised participants of the Ludwigshafen Risk and Cardiovascular Health (LURIC) study, all of whom underwent coronary angiography. Participants were stratified based on their serum concentrations of hsCRP, SAA, and IL-6. Associations between biomarker combinations and mortality were assessed using multivariate Cox regression and ROC analysis. Individuals with elevated hsCRP and SAA or IL-6 showed higher prevalence rates of coronary artery disease, heart failure, and adverse metabolic traits. These “both high” groups had lower estimated glomerular filtration rate, higher NT-proBNP, and increased HbA1c. Combined elevations of hsCRP and SAA were significantly associated with higher all-cause and cardiovascular mortality in partially adjusted models. However, these associations weakened after adjusting for IL-6. IL-6 alone demonstrated the highest predictive power (AUC: 0.638) and improved risk discrimination when included in multi-marker models. The co-elevation of hsCRP, SAA, and IL-6 identifies a high-risk phenotype characterised by greater cardiometabolic burden and increased mortality. IL-6 may reflect upstream inflammatory activity and could serve as a therapeutic target. Multi-marker inflammatory profiling holds promise for refining cardiovascular risk prediction and advancing personalised prevention strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersCardiovascular DiseasesInterleukin-6InflammationHumansMaleFemaleC-Reactive ProteinSerum Amyloid A ProteinMiddle AgedAgedPrognosisRisk Factors

Stichwörter der Autor:innen

biomarkerscardiovascular riskhigh-sensitive C-reactive protein (hsCRP)inflammationinterleukin-6mortalityrisk stratificationserum amyloid A

Substanzen

BiomarkersC-Reactive ProteinSerum Amyloid A ProteinInterleukin-6

Autor:innen und Institutionen

  • Department of Medicine I (Cardiology, Hemostaseology, Medical Intensive Care), Medical Faculty Mannheim, University of Heidelberg, 68167 Mannheim, Germany.
  • LURIC Study gGmbH, Josef-Mörtl-Straße 23, 86482 Aystetten, Germany.
  • Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, 8036 Graz, Austria.
  • Federal Institute for Drugs and Medical Services, 53175 Bonn, Germany.
  • Medical Faculty Mannheim, University of Heidelberg, 68167 Mannheim, Germany.
  • Department of Medicine III (Cardiology, Pneumonology, Angiology), Medical Faculty Heidelberg, University of Heidelberg, 69120 Heidelberg, Germany.

ORCID-Profile: Angela P Moissl, Hubert Scharnagl, Bernhard K Krämer, Daniel Duerschmied, Winfried März, Marcus E Kleber

Förderung

  • European Union Horizon 2020 Program To_aition
  • Horizon 2020 Program TO_AITION

Zitieren

APA

Moissl, A. P., Delgado, G. E., Scharnagl, H., Siekmeier, R., Krämer, B. K., Duerschmied, D., März, W., & Kleber, M. E. (2025). Comparing Inflammatory Biomarkers in Cardiovascular Disease: Insights from the LURIC Study. International Journal of Molecular Sciences, 26(15), 7335. https://doi.org/10.3390/ijms26157335

Vancouver

Moissl AP, Delgado GE, Scharnagl H, Siekmeier R, Krämer BK, Duerschmied D, et al. Comparing Inflammatory Biomarkers in Cardiovascular Disease: Insights from the LURIC Study. International Journal of Molecular Sciences. 2025;26(15):7335. doi:10.3390/ijms26157335

BibTeX
@article{Moissl2025,
  author = {Moissl, Angela P and Delgado, Graciela E and Scharnagl, Hubert and Siekmeier, Rüdiger and Krämer, Bernhard K and Duerschmied, Daniel and März, Winfried and Kleber, Marcus E},
  title = {Comparing Inflammatory Biomarkers in Cardiovascular Disease: Insights from the LURIC Study},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {15},
  pages = {7335},
  doi = {10.3390/ijms26157335}
}
Kostenlos starten →